Cite

HARVARD Citation

    Farago, A. et al. (2015). Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer. Journal of thoracic oncology. 10 (12), p. . [Online]. 
  
Back to record